promoter SNP (rs405509 or −219T) and the two SNPs that determine the APOE 4 genotype (rs429358-rs7412 CC) that increases the risk for LOAD when the alleles are present in cis on the same chromosome [10] . Additionally, they show that this haplotype is significantly associated with younger age at diagnosis when compared to haplotypes that contain the G form of the −219 SNP and the APOE 4 allele, which suggests a link to earlier disease onset. Notably, the authors stress the importance of the occurrence of the associated alleles in cis, or in phase, in their analyses [10] . Prior studies, where the phase of the alleles on the chromosome was not determined or was estimated by inference, had limited power to measure complex interactions of specific alleles at multiple polymorphic sites in the genomic interval of chromosome 19 that includes APOE and several other genes.
Phylogenetic analyses are widely employed in medicine to explore the evolutionary relationships between, and the emergence of mutations in, human pathogens, but these analyses are less commonly used to identify disease-associated variation in the human genome [13] [14] [15] [16] . The branching tree representations of variations in gene sequences, like that in Fig. 1 , illustrate the relationships among the sequences or the different evolutionary lineages of the chromosomes in the sampled population. In the special case of a region of high linkage disequilibrium (LD), or low recombination, mutations stay connected during evolution. This pattern of co-inheritance can provide a view of the order (or timing) for each mutation in a region of interest. The phylogeny illustrated in Fig. 1 Fig. 1 . The annotated phylogenetic tree shows the mapping of rs10524523 polyT lengths and TOMM40 rs8106922 and APOE rs405509 (−219) SNPs. The case/control ratio for the two major clades is reported. For major clade B, which is associated with lower risk of LOAD and contains haplotypes linked to APOE 3, rs10524523 lengths are uniformly short (mean = 15.9, SEM = 0.4, n = 63). In contrast, the polyT alleles in clade A are much longer: the average length of alleles connected to APOE 4 is 27.2 (SEM = 0.29, n = 55, 'long') and the average length of polyT alleles connected to APOE 3 is 31.57 (SEM = 0.48, n = 90, 'very long'). There is strong bootstrap support (973/1000) for the first major branch and moderate bootstrap support for the branches within clade A (247/1000 and 776/1000, respectively). The tree is obtained from a cohort of 105 patients (210 haplotypes) (Arizona cohort) [11] . mosome 19 from LOAD patients and controls. This genomic region includes the three APOE promoter polymorphisms (−219, −491 and −427) discussed by Lescai et al. [10] . Events such as mutation and recombination in an ancestral sequence, represented by a node in the tree, introduce diversity in each chromosome and the resultant lineages subsequently inherit the outcomes of these events. If an inherited mutation causes a phenotype, such as disease susceptibility, the phenotype will tend to be enriched in a lineage that arises from the genetic event [17] . Each of the leaves of the tree, as shown on the right of the Fig. 1 , is composed of clusters of the most similar sequences from the sampled chromosomes. In Fig. 1 , distinct lengths of a variable-length, deoxythymidine homopolymer (polyT), rs10524523 or 523, located in intron 6 of the TOMM40 gene differentiate the leaves on this phylogeny. If a phylogeny is developed from a genomic region that is associated with disease, then each cluster of related haplotypes on the tree can be tested for association with a phenotype of interest, and the variants that distinguish each cluster can be further analyzed.
The phylogeny shown in Fig. 1 was originally published in our recent paper entitled, "A TOMM40 variable length polymorphism predicts the age of lateonset Alzheimer's disease" [12] . The major findings of this analysis of LOAD were in Caucasians: 1) APOE 4 was, almost without exception, linked to a long polyT repeat at rs10524523; 2) The 3 allele of APOE was linked to either a short (<20 T residues) polyT or a very long (>30 T residues) polyT repeat; and 3) The 'long' (L) or 'very long' (VL) polyT alleles, which refer to homopolymer lengths greater than 20 and 30 T residues respectively, were associated with earlier age of disease onset in APOE 3/4 patients (∼7 years difference) and with higher disease risk. That is, linkage to a short or very long poly-T for an APOE 3 carrier resulted in later or earlier onset of LOAD, respectively, regardless of risk imparted by APOE 4 [11] . This finding has now been extended to other APOE genotypes, including APOE 3/3 patients, where it has been demonstrated that those who are homozygous for the longer alleles have disease onset an average of 9 years earlier than those who carry one short polyT [18] .
We mapped the three APOE promoter polymorphisms (−219, −491 and −427), discussed by Lescai et al. [10] to the data for the three clinical cohorts in our 2009 publication. The three SNPs in the APOE promoter tend to be in linkage with specific polyT lengths. In Caucasians, the strongest linkages are between −219 G and short polyTs and −219 T and long or very long polyTs. The phylogeny in Fig. 1 is further annotated here with the alleles of the −219 promoter SNPs. The two major conclusions of this mapping are: 1) The T allele of −219 always maps to clade A. This clade is associated with a higher risk for LOAD and an earlier age of onset for LOAD relative to clade B; and 2) the T allele of −219 always co-occurs with either a long 523 allele linked to APOE 4 or a very long 523 allele linked to APOE 3. The association between the two alleles of −219 and distinct lengths of 523 potentially extends the findings of Lescai et al. [10] from individuals possessing the APOE 4 allele to 3 carriers as well.
The rs8106922 SNP in intron 6 of the TOMM40 gene remains the one variant within the 10 kilobase genomic region that best separates clades A and B in the consensus phylogenetic tree constructed for the APOE LD region. In the 105 subject cohort from the Arizona Alzheimer's Disease Research Center (ADCC, [12] ), the G allele of rs8106922 is linked to the G allele of −219 for 100% of all haplotypes. For 82% of the clade A haplotypes, the A allele of rs8106922 is linked to the T allele of −219. The remainder of clade A haplotypes have the A allele of rs8106922 linked to −219 G. The alleles of this TOMM40 SNP are therefore more characteristic of the two major clades. The correspondence between the indicated alleles of these two SNPs is statistically significant (p < 0.0001) by Fisher's exact test. Although rs8106922 distinguishes the two major clades better, −219 and several other SNPs in this region are also highly significant in terms of differentiating the clades. Interestingly, a meta-analysis of five LOAD case-control studies indicates that rs8106922 is significantly associated with disease risk, with a studywide allelic odds ratio of 2.7 [19] . Several other SNPs in TOMM40 are highly significantly associated with LOAD, some with allelic odds ratios in the 2.8-3.0 range, which provides further evidence for a role for this gene in LOAD [20] [21] [22] [23] .
The APOE promoter SNP, −219, described by Lescai et al. [10] , is not significantly associated with age of LOAD onset in the APOE 3/4 cohort that we analyzed for age of onset in 2009 (p > 0.51). However, we do identify a trend that is in accord with their findings: we calculate that the age of LOAD onset for individuals who have the TT −219 genotype is earlier (70.1 ± 1.8, n = 15) than the age of onset for the GT genotype (73.1 ± 1.7, n = 12) or GG genotype (72.0 ± 3.0, n = 7) in our cohort. In contrast, the 523-polyT genotype is a better age of onset classifier and is more statistically significant. That is, for APOE 3/4 patients who developed LOAD after age 60, the individuals with long polyT repeats linked to APOE 3 developed LOAD an average of 7 years earlier than individuals with shorter poly-T repeats linked to APOE 3 (70.5 years ± 1.2 versus 77.6 years ± 2.1, p = 0.02, n = 34) [12] .
TOMM40 and APOE are in LD on chromosome 19, with the 3 and 5 ends, respectively, of the genes, separated by only ∼2 kilobases [7, 24] . The proximity of the genes and the LD within the region may obscure disease risk associated with variants other than APOE 4. As noted by Lescai et al. [10] , the amount of ApoE protein in cerebral spinal fluid of non-demented individuals and in postmortem brain of LOAD patients is associated with SNPs within TOMM40 and not with APOE SNPs, suggesting that an APOE-regulatory element may reside in TOMM40 [25, 26] .
In addition to the genetics, there are other data indicating that Tom40, the protein encoded by TOMM40, is directly involved in LOAD pathogenesis. Tom40 is the transmembrane channel subunit of the Translocase of the Outer Mitochondrial Membrane (TOM) complex. Almost all proteins involved in mitochondrial structure and function are encoded by nuclear genes and are translocated into mitochondria through this pore. Because >98% of the 1100 to 1500 known mitochondrial proteins [27] are nuclear encoded and enter mitochondria through Tom40 [28] , this protein plays a critical role in mitochondrial physiology and biogenesis and therefore overall cellular health and functioning. A role for Tom40 in mitochondrial pathogenesis, proposed to be a precipitating event in Alzheimer's disease, is indicated by the finding of amyloid-␤ protein precursor (A␤PP) lodged in the TOM channel in LOAD brain samples. This blockage results in mitochondrial dysfunction due to obstruction of the transport of nuclear-encoded cytochrome c oxidase (COX) subunits into the mitochondrion [29, 30] . Decreased COX activity gives rise to increased generation of reactive oxygen species and reduced ATP production. A␤PP-induced mitochondrial toxicity is observed in samples from LOAD patients and not in samples from normal, age-matched controls, and the extent of bound A␤PP is positively correlated with disease severity. Tom40 also mediates the passage of A␤ peptide, a fragment of A␤PP, from the cytosol into mitochondria, where it induces mitotoxicity by inhibiting COX [31, 32] . There is, therefore, genetic and cell biological evidence that TOMM40 contributes to LOAD risk or pathogenesis.
In summary, Lescai and colleagues [10] present important data on the role of SNPs in the APOE promoter and their possible interaction with variants of the APOE gene. Moreover, the report makes a compelling case for considering the cis arrangement of alternative alleles in analyses of disease phenotypes, as different allelic combinations may engender different biology. Analyzing the APOE promoter SNPs in the context of the molecular evolution of the extended LD interval shows the linkage between specific APOE promoter alleles and the APOE 3-very long 523 haplotype that is associated with LOAD risk and earlier disease onset, in addition to the interaction of the promoter alleles with APOE 4 that Lescai et al. describe. The data presented by Lescai et al. [10] , and in this Commentary, provide additional support for rs10524523 as a predictive marker for disease onset. This genetic marker provides a viable strategy for enrichment of clinical trials to test therapies that may alleviate or offset mitochondrial dysfunction and thereby delay the onset of LOAD.
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